研究者業績

鈴木 敦詞

スズキ アツシ  (Suzuki Atsushi)

基本情報

所属
藤田医科大学 医学部 内分泌・代謝・糖尿病内科学 教授
学位
医学博士(名古屋大学大学院)

J-GLOBAL ID
200901065882187333
researchmap会員ID
5000024859

学歴

 2

受賞

 5

論文

 252
  • Kanako DEGUCHI, Chihiro USHIRODA, Yuka KAMEI, Kyosuke KONDO, Hiromi TSUCHIDA, Yusuke SEINO, Daisuke YABE, Atsushi SUZUKI, Shizuko NAGAO, Katsumi IIZUKA
    Journal of Nutritional Science and Vitaminology 71(1) 46-54 2025年2月28日  
  • Kanako Deguchi, Chihiro Ushiroda, Shihomi Hidaka, Hiromi Tsuchida, Risako Yamamoto-Wada, Yusuke Seino, Atsushi Suzuki, Daisuke Yabe, Katsumi Iizuka
    Nutrients 17(3) 2025年1月29日  
    Background/Objectives: Carbohydrate and protein restriction are associated with sarcopenia and osteopenia, but the underlying mechanisms remain unclear. We aimed to determine whether mild protein restriction affects muscle and bone function in wild-type (WT) and homozygous carbohydrate response element binding protein (Chrebp) knockout (KO) mice. Methods: Eighteen-week-old male wild-type and homozygous carbohydrate response element binding protein (Chrebp) knockout (KO) mice were fed a control diet (20% protein) or a low-protein diet (15% protein) for 12 weeks. We estimated the muscle weight and limb grip strength as well as the bone mineral density, bone structure, and bone morphometry. Results: Chrebp deletion and a low-protein diet additively decreased body weight (WT control-KO low-protein: mean difference with 95% CI, 8.7 [6.3, 11.0], p < 0.0001) and epidydimal fat weight (1.0 [0.7, 1.2], p < 0.0001). Chrebp deletion and a low-protein diet additively decreased tibialis anterior muscle weight (0.03 [0.01, 0.05], p = 0.002) and limb grip strength (63.9 [37.4, 90.5], p < 0.0001) due to a decrease in insulin/insulin-like growth factor 1 mRNA and an increase in myostatin mRNA. In contrast, Chrebp deletion increased bone mineral density (BMD) (WT control-KO control: -6.1 [-1.0, -2.3], p = 0.0009), stiffness (-21.4 [-38.8, -4.1], p = 0.011), cancellous bone BV/TV (-6.517 [-10.99, -2.040], p = 0.003), and the number of trabeculae (-1.1 [-1.8, -0.5], p = 0.0008). However, in KO mice, protein restriction additively decreased BMD (KO control-KO low-protein: 8.1 [4.3, 11.9], p < 0.0001), bone stiffness (38.0 [21.3, 54.7], p < 0.0001), cancellous bone BV/TV (7.7 [3.3, 12.2], p = 0.006), and the number of trabeculae (1.2 [0.6, 1.9], p = 0.0004). The effects of mild protein restriction on bone formation parameters (osteoid volume (WT control-WT low-protein: -1.7 [-2.7, -0.7], p = 0.001) and the osteoid surface (-11.2 [-20.8, -1.5], p = 0.02) were observed only in wild-type (WT) mice. The levels of bone resorption markers, such as the number of osteoclasts on the surface, the number of osteoclasts, and surface erosion, did not differ between the groups. Conclusions: Both Chrebp deletion and protein restriction led to a decrease in muscle and bone function; therefore, an adequate intake of carbohydrates and proteins is important for maintaining muscle and bone mass and function. Further studies will be needed to elucidate the mechanisms by which ChREBP deletion and a low-protein diet cause osteosarcopenia.
  • Akiko Yamamoto, Nagisa Komatsu, Naoko Iwata, Haruki Fujisawa, Atsushi Suzuki, Yoshihisa Sugimura
    JCEM case reports 3(1) luae214 2025年1月  
    Lymphocytic infundibuloneurohypophysitis (LINH) is a disease with an etiology involving an autoimmune mechanism, characterized by lymphocytic inflammation of the posterior pituitary and infundibular stalk, resulting in arginine vasopressin deficiency. It is difficult to distinguish from pituitary neoplasm or infiltrative diseases, and biopsy is necessary for a definitive diagnosis, but this is highly invasive. In children, it is especially important to distinguish LINH from tumors such as germ cell tumors. Recently, the usefulness of anti-rabphilin-3A antibody as a serum marker for LINH has been reported. To date, only a limited number of pediatric cases have been reported. We present a 4-year-old boy with arginine vasopressin deficiency. Magnetic resonance imaging of the head showed thickening of the pituitary stalk without a posterior pituitary bright spot, and anti-rabphilin-3A antibody was positive. Consequently, pituitary biopsy was not performed because of the strong suspicion of LINH. Five months after symptom onset, the pituitary stalk thickening had resolved. This case represents the first report of probable or definitive LINH with anti-rabphilin-3A antibody positivity in a 4-year-old child, making it the youngest positive case reported to date. Our case highlights the importance of noninvasive approaches and careful follow-up to avoid invasive interventions for children with LINH.
  • 堀 景太朗, 川島 知也, 福田 真也, 今井 理紗子, 藤澤 太郎, 堀田 亮輔, 酒井 勝央, 山田 明子, 藤沢 治樹, 鈴木 敦詞, 椙村 益久, 高見 和久
    日本内分泌学会雑誌 100(4) 1005-1005 2024年12月  
  • Yasumasa Yoshino, Tomoka Hasegawa, Shukei Sugita, Eisuke Tomatsu, Naoya Murao, Izumi Hiratsuka, Sahoko Sekiguchi-Ueda, Megumi Shibata, Takeo Matsumoto, Norio Amizuka, Yusuke Seino, Takeshi Takayanagi, Yoshihisa Sugimura, Atsushi Suzuki
    Fujita medical journal 10(4) 87-93 2024年11月  
    OBJECTIVES: Phosphate (Pi) induces differentiation of arterial smooth muscle cells to the osteoblastic phenotype by inducing the type III Na-dependent Pi transporter Pit-1/solute carrier family member 1. This induction can contribute to arterial calcification, but precisely how Pi stress acts on the vascular wall remains unclear. We investigated the role of extracellular Pi in inducing microstructural changes in the arterial wall. METHODS: Aortae of Pit-1-overexpressing transgenic (TG) rats and their wild-type (WT) littermates were obtained at 8 weeks after birth. The thoracic descending aorta from WT and TG rats was used for the measurement of wall thickness and uniaxial tensile testing. Structural and ultrastructural analyses were performed using light microscopy and transmission electron microscopy. Gene expression of connective tissue components in the aorta was quantified by quantitative real-time polymerase chain reaction. RESULTS: Aortic wall thickness in TG rats was the same as that in WT rats. Uniaxial tensile testing showed that the circumferential breaking stress in TG rats was significantly lower than that in WT rats (p<0.05), although the longitudinal breaking stress, breaking strain, and elastic moduli in both directions in TG rats were unchanged. Transmission electron microscopy analysis of the aorta from TG rats showed damaged formation of elastic fibers in the aortic wall. Fibrillin-1 gene expression levels in the aorta were significantly lower in TG rats than in WT rats (p<0.05). CONCLUSIONS: Pi overload acting via the arterial wall Pit-1 transporter weakens circumferential strength by causing elastic fiber malformation, probably via decreased fibrillin-1 expression.

MISC

 283
  • 鈴木 敦詞, 佐藤 哲郎, 磯崎 収, 脇野 修, 飯降 直男, 坪井 久美子, 門傳 剛, 幸喜 毅, 金本 巨哲, 大谷 肇, 手良向 聡, 赤水 尚史
    日本内分泌学会雑誌 87(2) 500-500 2011年9月  
  • Megumi Shibata, Atsushi Suzuki, Takao Sekiya, Sahoko Sekiguchi, Shogo Asano, Yasuhiro Udagawa, Mitsuyasu Itoh
    JOURNAL OF BONE AND MINERAL METABOLISM 29(5) 615-620 2011年9月  
    Serum 25-hydroxyvitamin D (25-OHD) concentrations are thought to accurately reflect vitamin D stores, and vitamin D deficiency causes secondary hyperparathyroidism, irreversible bone loss, and increased risk of fracture. Recent studies suggest that decrease of serum 25-OHD level in mothers could increase the risk of preeclampsia, cesarean section, and craniotabes. Furthermore, this deficiency may affect bone mass and the incidence of neuromuscular diseases of their children in the future. In the present study, the serum concentration of 25-OHD in 93 pregnant women after the 30th week of their gestation was determined by direct radioimmunoassay. Mean 25-OHD levels in spring, summer, fall, and winter were 14.3 +/- 5.1, 15.7 +/- 6.4, 13.7 +/- 5.1, and 13.9 +/- 4.2 ng/ml, respectively. Severe vitamin D deficiency (25-OHD &lt; 10 ng/ml) was found in 10 of these 93 women. Overall, hypovitaminosis D, which was defined as serum 25-OHD concentration equal to or less than 20 ng/ml, was revealed in 85 mothers (89.5%). Serum 25-OHD levels were not associated with either intact parathyroid hormone or corrected calcium concentrations, but were negatively associated with serum type I collagen N-terminal telopeptide and bone-specific alkaline phosphatase in these subjects. Mothers with threatened premature delivery had significantly lower 25-OHD levels (11.2 +/- 3.2 ng/ml) than those in mothers with normal delivery (15.6 +/- 5.1 ng/ml). In conclusion, the present data suggest a high prevalence of hypovitaminosis D in perinatal pregnant Japanese women throughout the year, which seems to affect bone metabolism and to be associated with threatened premature delivery.
  • Hirotaka Yoshioka, Yuji Yoshiko, Tomoko Minamizaki, Sayaka Suzuki, Yoshiro Koma, Asako Nobukiyo, Yusuke Sotomaru, Atsushi Suzuki, Mitsuyasu Itoh, Norihiko Maeda
    CALCIFIED TISSUE INTERNATIONAL 89(3) 192-202 2011年9月  
    Inorganic phosphate (Pi) is required in many biological processes, including signaling cascades, skeletal development, tooth mineralization, and nucleic acid synthesis. Recently, we showed that Pi transport in osteoblasts, mediated by Slc20a1, a member of the type III sodium-dependent phosphate transporter family, is indispensable for osteoid mineralization in rapidly growing rat bone. In addition, we found that bone mineral density decreased slightly with dysfunction of Pi homeostasis in aged transgenic rats overexpressing mouse Slc20a1 (Slc20a1-Tg). Bone and tooth share certain common molecular features, and thus, we focused on tooth development in Slc20a1-Tg mandibular incisors in order to determine the role of Slc20a1 in tooth mineralization. Around the time of weaning, there were no significant differences in serologic parameters between wild-type and Slc20a1-Tg rats. However, histological analysis showed that Slc20a1-Tg ameloblasts formed clusters in the papillary layer during the maturation stage as early as 4 weeks of age. These pathologies became more severe with age and included the formation of cyst-like or multilayer ameloblast structures, accompanied by a chalky white appearance with abnormal attrition and fracture. Hyperphosphatemia was also observed in aging Slc20a1-Tg rats. Micro-computed tomography and electron probe microanalysis revealed impairments in enamel, such as delayed mineralization and hypomineralization. Our results suggest that enamel formation is sensitive to imbalances in Pit1-mediated cellular function as seen in bone, although these processes are under the control of systemic Pi homeostasis.
  • 原 武志, 早川 伸樹, 城 久美子, 木村 麻衣子, 牧野 真樹, 鈴木 敦詞, 織田 直久, 伊藤 光泰
    糖尿病 54(5) 385-385 2011年5月  
  • 吉野 寧維, 織田 直久, 横山 敦司, 牧野 真樹, 高柳 武志, 早川 伸樹, 鈴木 敦詞, 伊藤 光泰
    糖尿病 54(Suppl.1) S-175 2011年4月  
  • 牧野 真樹, 鈴木 敦詞, 城 久美子, 吉野 寧維, 木村 麻衣子, 横山 敦司, 関口 佐保子, 四馬田 恵, 高柳 武志, 早川 伸樹, 織田 直久, 吉田 淳一, 杉谷 篤, 伊藤 光泰
    糖尿病 54(Suppl.1) S-302 2011年4月  
  • 湯澤由紀夫, 小山勝志, 鈴木敦詞, 岩瀬三紀, 齋藤誠
    血圧 18(4) 409-414 2011年4月  
  • Sahoko Sekiguchi, Atsushi Suzuki, Shogo Asano, Keiko Nishiwaki-Yasuda, Megumi Shibata, Shizuko Nagao, Naoki Yamamoto, Mutsushi Matsuyama, Yutaka Sato, Kunimasa Yan, Eishin Yaoita, Mitsuyasu Itoh
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY 300(4) F848-F856 2011年4月  
    Sekiguchi S, Suzuki A, Asano S, Nishiwaki-Yasuda K, Shibata M, Nagao S, Yamamoto N, Matsuyama M, Sato Y, Yan K, Yaoita E, Itoh M. Phosphate overload induces podocyte injury via type III Na-dependent phosphate transporter. Am J Physiol Renal Physiol 300: F848-F856, 2011. First published February 9, 2011; doi:10.1152/ajprenal.00334.2010.-Uptake of Pi at the cellular membrane is essential for the maintenance of cell viability. However, phosphate overload is also stressful for cells and can result in cellular damage. In the present study, we investigated the effects of the transgenic overexpression of type III Pi transporter Pit-1 to explore the role of extracellular Pi in glomerular sclerosis during chronic renal disease. Pit-1 transgenic (TG) rats showed progressive proteinuria associated with hypoalbuminemia and dyslipidemia. Ultrastructural analysis of TG rat kidney by transmission electron microscopy showed a diffuse effacement of the foot processes of podocytes and a thickening of the glomerular basement membrane, which were progressively exhibited since 8 wk after birth. TG rats died at 32 wk of age due to cachexia. At this time, more thickening of the glomerular basement membrane and segmental sclerosis were observed in glomeruli of the TG rats. Immunohistochemical examination using anticonnexin 43 and anti-desmin antibodies suggested the progressive injury of podocytes in TG rats. TG rats showed higher Pi uptake in podocytes than wild-type rats, especially under low Pi concentration. When 8-wk-old wild-type and TG rats were fed a 0.6% normal phosphate (NP) or 1.2% phosphate (HP) diet for 12 wk, HP diet-treated TG rats showed more progressive proteinuria and higher serum creatinine levels than NP diet-treated TG rats. In conclusion, our findings suggest that overexpression of Pit-1 in rats induces phosphate-dependent podocyte injury and damage to the glomerular barrier, which result in the progression of glomerular sclerosis in the kidney.
  • 鈴木 敦詞, 吉野 寧維
    内分泌・糖尿病・代謝内科 39(4) 355-358 2011年  
  • 赤水 尚史, 佐藤 哲郎, 磯崎 収, 鈴木 敦詞, 脇野 修, 飯降 直男, 坪井 久美子, 門傳 剛, 幸喜 毅, 大谷 肇, 手良向 聡
    内科 107(1) 115-118 2011年1月  
    ・甲状腺クリーゼは「生命が危険となるような激しい症状を呈する甲状腺中毒症」であり、多臓器における非代償性状態を特徴とする。・甲状腺診療における救急の代表例である。・臨床症状に基づいて診断され、最近、日本における診断基準が樹立された。同診断基準に基づいて、わが国における全国疫学調査が実施された。・致死的疾患であるので、疑診の段階でも治療を開始することが肝要である。(著者抄録)
  • Fumiko Yokota, Tsutomu Yamada, Chinatsu Matsunaga, Hiroko Okazaki, Takashi Tominaga, Yuko Yambe, Yasuhisa Kato, Yoriko Funahashi, Atsushi Suzuki
    BMJ Case Reports 2011年  
  • 吉野寧維, 市川茉莉, 横山敦司, 織田直久, 早川伸樹, 鈴木敦詞, 伊藤光泰, 桐山諭和, 浦野誠, 黒田誠
    日本内科学会雑誌 100(11) 3329-3332 2011年  
    副甲状腺ホルモン関連蛋白(PTH-rP)は悪性腫瘍に伴う高Ca血症の原因として知られている.症例は78歳男性.1カ月前からの食欲低下,腰痛で発症した.高カルシウム血症を呈し,画像所見から肝臓,脾臓,腰椎・肋骨への多発転移巣が認められた.いずれも病理所見上アポクリン腺癌の転移であり,陰嚢部原発巣を含め免疫組織染色でPTH-rP産生が確認された.アポクリン腺癌によるPTH-rP産生の報告はなく,貴重な症例と考えられた為,報告する.<br>
  • 伊藤幸, 早川伸樹, 岡村智子, 髙柳武志, 鈴木敦詞, 織田直久, 植田晃広, 稲熊容子, 恵美宣彦, 伊藤光泰
    日本内科学会雑誌 100(10) 3038-3040 2011年  
    POEMS症候群は形質細胞の増殖異常と多発神経炎を中核とした多臓器病変を伴う疾患である.症例は32歳男性.倦怠感を機に副腎皮質機能低下症と診断されコートリルが投与されたが,諸症状の改善を認めず精査入院となった.その後POEMS症候群と診断,自己末梢血幹細胞移植を施行された.内分泌障害を機に診断されたPOEMS症候群の1例であり移植後軽快状態にあり,現在内分泌障害の改善を経過観察中である.<br>
  • 鈴木敦詞
    ホルモンと臨床 別冊 59(4) 1(317)-2(8) 2011年  
  • 鈴木 敦詞, 城 久美子, 吉野 寧維, 木村 麻衣子, 横山 敦司, 関口 佐保子, 四馬田 恵, 高柳 武志, 柿澤 弘章, 牧野 真樹, 早川 伸樹, 織田 直久, 梶 博史, 伊藤 光泰
    日本内分泌学会雑誌 86(3) 731-731 2010年12月  
  • 久徳 政代, 早川 伸樹, 城 久美子, 木村 麻衣子, 高柳 武志, 牧野 真樹, 日比 八束, 鈴木 敦詞, 織田 直久, 伊藤 光泰
    日本内分泌学会雑誌 86(3) 748-748 2010年12月  
  • 関口 佐保子, 城 久美子, 木村 麻衣子, 四馬田 恵, 吉野 寧維, 横山 敦司, 牧野 真樹, 早川 伸樹, 織田 直久, 鈴木 敦詞, 伊藤 光泰
    日本内分泌学会雑誌 86(2) 275-275 2010年9月  
  • 磯崎 収, 佐藤 哲郎, 鈴木 敦詞, 脇野 修, 飯降 直男, 坪井 久美子, 門傳 剛, 幸喜 毅, 大谷 肇, 手良向 聡, 赤水 尚史
    日本内分泌学会雑誌 86(2) 249-249 2010年9月  
  • 鈴木 敦詞, 坪井 久美子
    ホルモンと臨床 58(8) 679-684 2010年8月  
  • 飯降 直男, 脇野 修, 鈴木 敦詞
    ホルモンと臨床 58(8) 685-692 2010年8月  
  • Atsushi Suzuki, Sakura Yamamoto, Shougo Asano, Yasumasa Yoshino, Kumiko Hirai, Maiko Kimura, Atsushi Yokoyama, Tomoko Itoi, Sahoko Sekiguchi, Megumi Shibata, Takeshi Hara, Hiroaki Kakizawa, Nobuki Hayakawa, Naohisa Oda, Mitsuyasu Itoh
    ENDOCRINE JOURNAL 57 S382-S382 2010年3月  
  • Sahoko Sekiguchi, Megumi Shibata, Shougo Asano, Yasumasa Yoshino, Atsushi Yokoyama, Hiroaki Kakizawa, Nobuki Hayakawa, Naohisa Oda, Atsushi Suzuki, Mitsuyasu Itoh
    ENDOCRINE JOURNAL 57 S493-S494 2010年3月  
  • Atsushi Suzuki, Patrick Ammann, Keiko Nishiwaki-Yasuda, Sahoko Sekiguchi, Shogo Asano, Shizuko Nagao, Ryosuke Kaneko, Masumi Hirabayashi, Yutaka Oiso, Mitsuyasu Itoh, Joseph Caverzasio
    JOURNAL OF BONE AND MINERAL METABOLISM 28(2) 139-148 2010年3月  
    The type III inorganic phosphate (Pi) transporter Pit-1 was previously found to be preferentially expressed in developing long bones. Several studies also described a regulation of its expression in cultured bone cells by osteotropic factors, suggesting a role of this transporter in bone metabolism. In the present study, we investigated the effects of the transgenic overexpression of Pit-1 in Wistar male rats on calcium phosphate and bone metabolism. A threefold increase and doubling of Pi transport activity were recorded in primary cultured osteoblastic cells derived from calvaria of two transgenic (Tg) lines compared with wild-type littermates (WT), respectively. Skeletal development was not affected by the transgene, and bone mass, analyzed by DXA, was slightly decreased in Tg compared with WT. Enhanced Pi uptake in calvaria-derived osteoblasts from Pit-1 Tg was associated with a significantly decreased expression of alkaline phosphatase activity and a normal deposition and calcification of the collagenous matrix. In 4-month-old adult Tg rats, serum Pi and renal Pi transport were increased compared with WT. The decrease of serum Ca concentration was associated with increased serum parathyroid hormone levels. Variations in serum Pi in Pit-1 Tg rats were negatively correlated with serum fibroblast growth factor-23, whereas 1,25-dihydroxyvitamin D(3) was not affected by Pit-1 overexpression. In conclusion, transgenic Pit-1 overexpression in rats affected bone and calcium phosphate metabolism. It also decreased alkaline phosphatase activity in osteoblasts without influencing bone matrix mineralization as well as skeletal development.
  • T. Kato, Y. Sawai, H. Kanayama, H. Taguchi, T. Terabayashi, F. Taki, K. Yamada, Y. Yamazaki, N. Hayakawa, A. Suzuki, N. Oda, N. Katada, M. Itoh
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES 117(10) 593-599 2009年11月  
    The aim of this study was to determine whether a relatively low dose of pioglitazone or metformin was effective in diabetic patients with metabolic syndrome. Fifty diabetic patients with metabolic syndrome were randomly assigned to a low-dose pioglitazone (15mg/day) treatment group or a low-dose metformin (500mg/day) treatment group. Drugs were administered for 12 weeks. Systolic and diastolic blood pressure, heart rate, body mass index, triglyceride (TG), HDL and LDL-cholesterol, fasting plasma glucose (FPG), fasting plasma insulin (IRI), postprandial glucose, and HOMA-IR in the 75gOGTT, HbA1c, high-sensitivity CRP (hs-CRP) determined by cervical artery echography, and pulse wave velocity (PWV) were measured before/after 12-week drug administration. Significant decreases in HbA1c and HOMA-IR were noted in the pioglitazone group, along with significant decreases in TG, AST, ALT, blood pressure, hs-CRP and PWV. Significant decreases in HbA1c, HOMA-IR, BMI and waist circumference were noted in the metformin group. The pioglitazone group significantly improved the values for ALT, systolic blood pressure, hs-CRP and PWV compared to the metformin group. However, the metformin group demonstrated significant improvement in BMI compared with the pioglitazone group. Using a low dose regimen, pioglitazone significantly improved blood pressure and hepatic function and may be more effective than metformin to reduce risk factors in Japanese diabetic patients with metabolic syndrome at preventing atherosclerosis.
  • Shogo Asano, Atsushi Suzuki, Sahoko Sekiguchi, Keiko Nishiwaki-Yasuda, Megumi Shibata, Mitsuyasu Itoh
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS 81(4) 247-251 2009年10月  
    Inorganic phosphate (Pi) transport probably represents an important function of bone-forming cells in relation to extracellular matrix mineralization. In the present study, we investigated the effect of prostaglandin D-2 (PGD(2)) on Pi transport activity and its intracellular signaling mechanism in MC3T3-E1 osteoblast-like cells. PGD(2) stimulated Na-dependent Pi uptake time- and dose-dependently in MC3T3-E1 cells during their proliferative phase. A protein kinase C (PKC) inhibitor calphostin C partially suppressed the stimulatory effect of PGD(2) on Pi uptake. The selective inhibitors of mitogen-activated protein (MAP) kinase pathways such as ERK, p38 and Jun kinases suppressed PGD(2)-induced Pi uptake. The inhibitors of phosphaticlylinositol (PI) 3-kinase and S-6 kinase reduced this effect of PGD(2), while Akt kinase inhibitor did not. These results suggest that PGD(2) stimulates Na-dependent Pi transport activity in the phase of proliferation of osteoblasts. The mechanisms responsible for this effect are activation of PKC, MAP kinases, PI 3-kinase and S-6 kinase. (C) 2009 Elsevier Ltd. All rights reserved.
  • 加藤大也, 澤井喜邦, 金山均, 稲垣一道, 早川伸樹, 鈴木敦詞, 織田直久, 片田直幸, 伊藤光泰
    新薬と臨床 58(5) 73-77 2009年  
  • 浅野昇悟, 鈴木敦詞, 稲垣一道, 梅谷洋介, 関口佐保子, 糸井智子, 山元弘桜, 柿澤弘章, 早川伸樹, 織田直久, 伊藤光泰
    ホルモンと臨床 57(増刊) 14-19 2009年  
  • 四馬田恵, 鈴木敦詞, 関谷隆夫, 関口佐保子, 浅野昇悟, 柿澤弘章, 早川伸樹, 織田直久, 宇田川康博, 伊藤光泰
    Osteoporosis Japan 17(2) 100-103 2009年  
  • 鈴木敦詞
    Osteoporosis Japan 17(4) 9-11 2009年  
  • Akio Nagasaka, Naohisa Oda, Akira Nakai, Keiko Hotta, Mutsuko Nagata, Taiya Kato, Atsushi Suzuki, Mitsuyasu Itoh, Hitoshi Miura, Motoo Hakuta, Shonen Yoshida, Yatsuka Hibi, Katsumi Iwase
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 24(2) 524-530 2009年  
    Telomerase (TA) activity is known to be present in malignant tumor cells, but not in most somatic differentiated cells. TA shows relatively high activity in thyroid cancer cells, but reports vary. This fact prompted us to elucidate whether cell component inhibitors of TA in the thyroid follicles can modulate its activity. The activity of TA extracted from Hela cells was inhibited by mixing with the supernatant fraction of human thyroid tissue extract. To examine the effect of iodine, thyroid hormones (-T3 and -T4) and human thyroglobulin (hTg) contained in the thyroid follicles, -T3, -T4 and hTg were added to the TRAP assay system in vitro, using TA from Hela cells. Iodine, -T3 and -T4 did not affect TA activity, but hTg inhibited the TA activity in a dose-dependent manner (IC50 of hTg: ca 0.45M: inhibiting concentration of hTg was from 0.15M to 3.0M). The hTg inhibition was not evident in the RT-PCR system, suggesting no effect of hTg on Taq DNA polymerase activity. The hTg inhibition of TA activity was attenuated by dNTP but not significantly by TS primer. These data suggest that hTg contained in thyroid follicular cells of various thyroid diseases may affect the TA activity measured in biopsied thyroid specimens, and that the reduction of the TA activity by hTg may induce slow progression and growth, and low grade malignancy of thyroid cancer, particularly differentiated carcinoma.
  • 鈴木 敦詞, 伊藤 光泰
    日本内分泌学会雑誌 84(2) 400-400 2008年9月20日  
  • S. Sekiguchi, S. Asano, M. Shibata, A. Yokoyama, K. Inagaki, H. Kakizawa, N. Hayakawa, N. Oda, A. Suzuki, M. Itoh
    JOURNAL OF BONE AND MINERAL RESEARCH 23 S282-S282 2008年9月  
  • M. Shibata, S. Sekiguchi, Y. Umetani, S. Asano, T. Hara, H. Kakizawa, N. Hayakawa, N. Oda, A. Suzuki, M. Itoh
    JOURNAL OF BONE AND MINERAL RESEARCH 23 S486-S486 2008年9月  
  • S. Asano, S. Sekiguchi, M. Shibata, A. Yokoyama, K. Inagaki, H. Kakizawa, N. Hayakawa, N. Oda, A. Suzuki, M. Itoh
    JOURNAL OF BONE AND MINERAL RESEARCH 23 S250-S250 2008年9月  
  • 木村 麻衣子, 柿澤 弘章, 糸井 智子, 山元 弘桜, 四馬田 恵, 横山 敦司, 梅谷 洋介, 浅野 昇悟, 早川 伸樹, 鈴木 敦詞, 織田 直久, 伊藤 光泰
    日本内分泌学会雑誌 83(4) 1057-1057 2008年3月20日  
  • Shogo Asano, Atsushi Suzuki, Sahoko Sekiguchi, Megumi Shibata, Mitsuyasu Itoh
    ANNALS OF NUTRITION AND METABOLISM 53(1) 62-62 2008年  
  • 鈴木 敦詞, 関谷 隆夫, 中山 貴美也, 元仲 小織
    薬局 58(12) 3144-3152 2007年11月  査読有り
  • A. Shoo, S. Sekiguchi, A. Yokoyama, K. Inagaki, H. Kakizawa, N. Hayakawa, N. Oda, A. Suzuki, M. Itoh
    JOURNAL OF BONE AND MINERAL RESEARCH 22 S248-S248 2007年9月  
  • A. Suzuki, P. Amman, S. Sekiguchi, S. Asano, K. Nishiwaki-Yasuda, S. Nagao, H. Takahashi, M. Hirabayashi, M. Itoh
    JOURNAL OF BONE AND MINERAL RESEARCH 22 S394-S394 2007年9月  
  • S. Sekiuchi, S. Asano, K. Nishiwaki-Yasuda, A. Yokoyama, K. Inagaki, H. Kakizawa, N. Hayakawa, N. Oda, A. Suzuki, M. Itoh
    JOURNAL OF BONE AND MINERAL RESEARCH 22 S264-S264 2007年9月  
  • A. Suzuki, K. Nishiwaki-Yasuda, S. Sekiguchi, K. Inagaki, K. Umetani, S. Asano, T. Itoi, S. Yamamoto, M. Nagata, H. Kakizawa, N. Hayakawa, N. Oda, M. Itoh
    BONE 40(6) S208-S208 2007年6月  
  • 伊藤 光泰, 鈴木 敦詞, 早川 伸樹, 稲垣 一道, 牧野 真樹
    日本内分泌学会雑誌 83(1) 85-85 2007年4月  
  • 織田 直久, 小野 保長, 下村 敦司, 千田 隆夫, 石原 慎, 堀口 明彦, 宮川 秀一, 早川 伸樹, 鈴木 敦詞, 伊藤 光泰
    糖尿病 50(Suppl.1) S-216 2007年4月  
  • 赤水尚史, 佐藤哲郎, 磯崎収, 鈴木敦詞, 脇野修, 飯降直男, 坪井久美子, 門傳剛, 幸喜毅
    内科 100(5) 882-885 2007年  
  • 加藤 大也, 糸井 智子, 松本 崇, 今村 繁夫, 早川 伸樹, 鈴木 敦詞, 織田 直久, 水谷 有希, 澤井 喜邦, 伊藤 光泰
    ホルモンと臨牀 54 180-183 2006年9月30日  
  • A. Suzuki, P. Amman, K. Nishiwaki-Yasuda, S. Seiguchi, S. Nagao, H. Takahashi, K. Yan, M. Hirabayashi, M. Itoh, J. Caverzasio
    JOURNAL OF BONE AND MINERAL RESEARCH 21 S128-S128 2006年9月  
  • K Nishiwaki-Yasuda, A Suzuki, A Kakita, Y Ono, S Sekiguchi, K Inagaki, T Matsumoto, S Imamura, H Kakizawa, N Hayakawa, N Oda, Y Oiso, M Itoh
    JOURNAL OF BONE AND MINERAL RESEARCH 20(9) S195-S195 2005年9月  
  • S Sekiguchi, M Nagata, K Nishiwaki-Yasuda, Y Ono, K Inagaki, T Matsumoto, S Imamura, H Kakizawa, N Hayakawa, N Oda, A Suzuki, M Itoh
    JOURNAL OF BONE AND MINERAL RESEARCH 20(9) S162-S162 2005年9月  
  • A Suzuki, K Nishiwaki-Yasuda, J Caverzasio, Y Ono, S Sekiguchi, S Nagao, H Takahashi, M Matsuyama, K Yan, R Kaneko, M Hirabayashi, P Ammann, R Rizzoli, Y Oiso, M Itoh
    JOURNAL OF BONE AND MINERAL RESEARCH 20(9) S201-S201 2005年9月  

講演・口頭発表等

 158

共同研究・競争的資金等の研究課題

 3

その他

 2
  • 細胞内でのリン酸分子の移動を可視化する技術 *本研究ニーズに関する産学共同研究の問い合わせは藤田医科大学産学連携推進セン ター(fuji-san@fujita-hu.ac.jp)まで
  • III型リン酸トランスポーター過剰発現ラット(細胞外リン酸負荷によるポドサイト障害によるネフローゼ症候群を発現。Sekiguchi et al., Am J Physiol. 300(4): F848-856, 2011) *本研究シーズに関する産学共同研究の問い合わせは藤田医科大学産学連携推進セン ター(fuji-san@fujita-hu.ac.jp)まで

作成した教科書、教材、参考書

 2
  • 件名
    ガイトン生理学
    終了年月日
    2010
    概要
    第79章 副甲状腺ホルモン. p.1037を分担執筆
  • 件名
    内分泌診療のファーストタッチ
    終了年月日
    2013
    概要
    編者